Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma.

Johan W. Molling, JAE Langius, J.A. Langendijk, CR Leemans, HJ Bontkes, JJ van der Vliet, BME von Blomberg, RJ Scheper, AJM van den Eertwegh

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalJournal of Clinical Oncology
Publication statusPublished - 2007

Cite this